F40.2
Conditions
Interventions
Group 1: Healthy Controls: method A (1x15 min. exposure in virtual reality)
Group 2: Patients: method A (1x15 min. exposure in virtual reality) and method B (2x15 min. exposure in virtual reality)
Gro
Sponsors
Klinik und Poliklinik für Psychiatrie und Psychotherapie, Universitätsklinikum Münster
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 65 patients with acrophobia; 40 healthy matched controls
Exclusion criteria
Exclusion criteria: • psychiatric disorder other than secific phobia (comorbidity according to DSM-IV-TR) • acute suicidal intent • epilepsy or other illness of the central nervous system (brain tumor, encephalitis) • migraine • concomitant psychotherapy • concomitant medication with psychotropic drugs • pregnancy • history of heart disease or psychotic disorder
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of acophobic symptoms, evalued wiht Acrophobia Questionnaire (before and after each of the 3 exposures) and SUDS (Subjective Units of Discomfort; assessed during each of the 3 exposures) | — |
Secondary
| Measure | Time frame |
|---|---|
| Strength of autonomic arousal measured by the following pysiological measures: salivary Cortisol (during 1. exposure), heart rate and electrodermal activity (measured during all 3 exposures). In patients: Severity of height avoidance, measured by Behavioural Avoidance Test (before 2. and after 3. exposure). | — |
Countries
Germany
Contacts
Public ContactJulia Diemer
Klinik und Poliklinik für Psychiatrie und Psychotherapie, Universitätsklinikum Münster
Outcome results
None listed